Form S-8

Registration No. 333-            

As filed with the Securities and Exchange Commission on November 6, 2006


SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


FORM S-8

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 


ANGIODYNAMICS, INC.

(Exact name of registrant as specified in its charter)

 


 

Delaware   11-3146460

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

603 Queensbury Avenue

Queensbury, New York 12804

(Address of Principal Executive Offices) (Zip Code)

 


AngioDynamics, Inc. 2004 Stock and Incentive Award Plan

(Full title of the plan)

 


Eamonn P. Hobbs

AngioDynamics, Inc.

603 Queensbury Avenue

Queensbury, New York 12804

(Name and address of agent for services)

(518) 798-1215

(Telephone number, including area code, of agent for service)

 


Copy to:

Scott M. Tayne, Esq.

Davies Ward Phillips & Vineberg LLP

625 Madison Avenue, 12th Floor

New York, New York 10022

 


Calculation of Registration Fee

 


Title of Securities to be Registered(1)   

Amount to be

Registered(2)

  

Proposed Maximum

Offering
Price Per
Share(3)

   Proposed Maximum
Aggregate Offering Price
  

Amount of

Registration Fee

Common Stock par value, $.01 per share

   1,000,000 Shares    $ 21.945    $ 21,945,000    $ 2,348.12

Total

   1,000,000 Shares       $ 21,945,000    $ 2,348.12

(1) Includes preferred stock purchase rights which, until events specified in the registrant’s rights agreement occur, will not be exercisable or evidenced separately from the common stock. Value attributed to such rights, if any, is reflected in the market price of the common stock.
(2) In accordance with Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), there are also registered hereby such indeterminate number of shares of common stock as may become issuable by reason of the operation of the anti-dilution provisions of the AngioDynamics, Inc. 2004 Stock and Incentive Award Plan.
(3) Pursuant to Rules 457(c) and (h) under the Securities Act, the proposed maximum offering price per share was determined based upon the average of the high and low prices of the registrant’s common stock as reported by The Nasdaq Stock Market on October 31, 2006.

 



EXPLANATORY NOTE

On October 28, 2004, AngioDynamics, Inc. (the “Company” or “Registrant”) registered 1,000,000 shares of its common stock par value $0.01 per share (“Common Stock”) issuable under the AngioDynamics, Inc. 2004 Stock and Incentive Award Plan (the “2004 Plan”) pursuant to a Registration Statement on Form S-8 (File No. 333-120057). This Registration Statement on Form S-8 is being filed pursuant to General Instruction E to Form S-8 to register an additional 1,000,000 shares of Common Stock issuable under the 2004 Plan.

INCORPORATION BY REFERENCE

Pursuant to General Instruction E to Form S-8, the contents of the Registrant’s Registration Statement on Form S-8 (File No. 333-120057) filed with the Securities and Exchange Commission on October 28, 2004, are incorporated herein by reference.

PART II

ITEM 8. EXHIBITS

 

Exhibit

Number

 

Exhibit

5.1   Opinion of Davies Ward Phillips & Vineberg LLP
23.1   Consent of PricewaterhouseCoopers LLP
23.2   Consent of Grant Thornton LLP
23.3   Consent of Davies Ward Phillips & Vineberg LLP (included as part of Exhibit 5.1)
24.1   Power of Attorney (set forth on the signature page of the Registration Statement)

 

II-1


SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Queensbury, State of New York, on the 6th day of November, 2006.

 

AngioDynamics, Inc.
By:  

/s/ Eamonn P. Hobbs

  Eamonn P. Hobbs
  President and Chief Executive Officer

 

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each individual whose signature appears below constitutes and appoints Eamonn P. Hobbs and Joseph G. Gerardi, and each or any of them, his true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their, or his substitutes or substitute, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed below by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

/s/ Eamonn P. Hobbs

Eamonn P. Hobbs

  

President, Chief Executive Officer and Director

(Principal Executive Officer)

  November 6, 2006

/s/ Joseph G. Gerardi

Joseph G. Gerardi

  

Vice President and Chief Financial

Officer (Principal Financial and

Accounting Officer)

  November 6, 2006

/s/ Paul S. Echenberg

Paul S. Echenberg

   Chairman of the Board, Director   November 6, 2006

 

II-2


/s/ Jeffrey G. Gold

Jeffrey G. Gold

   Director   November 6, 2006

/s/ David P. Meyers

David P. Meyers

   Director   November 6, 2006

/s/ Howard W. Donnelly

Howard W. Donnelly

   Director   November 6, 2006

/s/ Dennis S. Meteny

Dennis S. Meteny

   Director   November 6, 2006

/s/ Robert E. Flaherty

Robert E. Flaherty

   Director   November 6, 2006

/s/ Gregory D. Casciaro

Gregory D. Casciaro

   Director   November 6, 2006

/s/ Peter J. Graham

     November 6, 2006
Peter J. Graham    Director  

 

II-3


EXHIBIT INDEX

 

Exhibit

Number

 

Exhibit

5.1   Opinion of Davies Ward Phillips & Vineberg LLP
23.1   Consent of PricewaterhouseCoopers LLP
23.2   Consent of Grant Thornton LLP
23.3   Consent of Davies Ward Phillips & Vineberg LLP (included as part of Exhibit 5.1)
24.1   Power of Attorney (set forth on the signature page of the Registration Statement)